Comparison of a ready-to-use liquid glucagon injection administered by autoinjector to glucagon emergency kit for the symptomatic relief of severe hypoglycemia: two randomized crossover non-inferiority studies

INTRODUCTION: To prevent medical sequelae of severe hypoglycemic emergencies, prompt and reliable rescue intervention is critically important. A ready-to-use, liquid stable glucagon, administered subcutaneously by glucagon autoinjector (GAI), Gvoke HypoPen (glucagon injection; Xeris Pharmaceuticals)...

Descripción completa

Detalles Bibliográficos
Autores principales: Christiansen, Mark P, Cummins, Martin, Prestrelski, Steven, Close, Nicole C, Nguyen, Anh, Junaidi, Khaled
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499286/
https://www.ncbi.nlm.nih.gov/pubmed/34620618
http://dx.doi.org/10.1136/bmjdrc-2021-002137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499286/
https://www.ncbi.nlm.nih.gov/pubmed/34620618
http://dx.doi.org/10.1136/bmjdrc-2021-002137

Ejemplares similares